CANCELLED/POSTPONED
It is with great regret that we have decided to cancel/postpone the first symposium to be held between Imperial College London and Johns Hopkins University, due to concerns over the COVID-19 virus. However, we will look to reschedule this event for a more suitable date later in the year once the situation becomes clearer.
Please join us for our first annual symposium which forms part of a new, ongoing collaboration between Imperial College London and Johns Hopkins University. The goal of this new initiative is to bring together a multi-disciplinary group of colorectal researchers and specialists from US and UK, to discuss the recent outstanding achievements in the field of colorectal cancer management and to further promote high quality research.
This is a one-day event, hosted by the CRUK Imperial Centre in the Sir Alexander Fleming Building, South Kensington Campus.
The symposium is free to attend, but you must purchase a ticket on Eventbrite to register.
This symposium is open to any researcher, clinician or healthcare worker/professional
PROGRAMME
08.00-08.45 Registration
08.45-09.00 Opening Remarks – Prof Ara Darzi, Imperial College London
Session 1: Registries – Guidelines – Epidemiology – US vs UK
09:05- 09:25 Miss Stella Nikolaou, Imperial College London
- Colorectal Cancer Registries and Guidelines: Comparing the United Kingdom and United States of America and the Call for International Standardization
09:25 – 09:45 Prof Amanda Cross, Imperial College London
- Epidemiology and Screening of CRC: What’s Changing?
09:45 – 10:05 Mr James Kinross, Imperial College London
- Is it in the ‘genes’ the ‘environment’ or the’ gut’?
10:05 – 10:25 Dr Atif Zaheer, Johns Hopkins University
- Rectal Cancer MRI: Staging and treatment response assessment
10.25-10.55 Morning coffee
Session 2: Neo-adjuvant/adjuvant treatments of rectal cancer
10:55 – 11:15 Prof Jonathan Efron, Johns Hopkins University
- Organ preservation in rectal cancer. How? When? Why?
11:15 – 11:35 Dr Haniee Chung, Johns Hopkins University
- Total neo-adjuvant treatment for rectal cancer
11:35 – 11:55 Prof Long Jiao, Imperial College London
- Synchronous metastatic disease. Primary or liver first?
11:55 – 12:15 Dr Adrian Murphy, Johns Hopkins University
- Immunotherapy Trials
12:15 – 13:15 Lunch
Session 3: Multidisciplinary discussion of rectal cancer cases
13:15 – 15:15 Panel members:
Prof David Cunningham, Prof Gina Brown, Dr Svetlana Balyasnikova, Dr Diana Tait, Dr Irene Chong, Dr Ian Chau, Dr Naureen Starling, Dr Sheela Rao, Dr Katharine Aitken, Mr Shahnawaz Rasheed, Mr Christos Kontovounisios, Prof Paris Tekkis, Dr Daniel Levine, Dr Andrew Wotherspoon, Prof Jonathan Efron, Dr Atif Zaheer, Dr Haniee Chung, Dr Adrian Murphy, Dr Bashar Safar
15:15 – 15:30 Afternoon tea
Session 4: Minimally invasive approaches to rectal cancer
15:30 – 15:50 Miss Sarah Mills, Imperial College London
- Local excision vs TME
15:50 – 16:10 Mr Oliver Warren, Imperial College London
- Laparoscopic vs Transanal TME approaches to rectal cancer
16:10 – 16:35 Dr Bashar Safar, Johns Hopkins University
- Robotic approaches to TME (Training – registry)
Session 5: Patient participation involvement
16:35 – 16:50 Mr Paul Finch, CEO Red Trouser Day Charity
16:50 – 17:00 Closing Remarks – Prof Paris Tekkis, Imperial College London
